Formulated medicine for treatment and prevention of opportunistic infectious diseases complicated by infection with lentivirus
US5576299A · kind A · utility
20Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 1993 |
| Grant date | Nov 19, 1996 |
| Priority date | — |
| Expiry date | Mar 2, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23L33/19
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The protein lactoferrin can be used both for treating and/or preventing of portunistic infections frequently complicating Immunodeficiency Virus positive animals including human beings. The protein greatly improves the quality of life in such immunodeficiency virus infected animals. The dosage of the protein is usually 0.1-100 mg/kg daily, and preferably 0.5-50 mg/kg.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.